⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001376684

Astellas Pharma Inc.

Reports to the SEC for 3 companies · TOKYO, M0

Transactions

6

Companies

3

Filings

3

CIK

0001376684

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-11-19	KYNBKYNTRA BIO, INC.C Conversion	Former 10% holder	CConversion	+4.97M sh	—	—	4,968,367
2014-11-19	KYNBKYNTRA BIO, INC. · Series D Convertible Preferred StockC Conversion	Former 10% holder	CConversion	−4.55M sh	—	—	0
2014-11-19	KYNBKYNTRA BIO, INC. · Series F Convertible Preferred StockC Conversion	Former 10% holder	CConversion	−1.21M sh	—	—	0
2014-11-19	KYNBKYNTRA BIO, INC. · Series G Convertible Preferred StockC Conversion	Former 10% holder	CConversion	−6.67M sh	—	—	0
2010-06-07	OSI PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+6.39M sh	$57.50	+$367M	57,232,357
2010-06-04	OSI PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+1.18M sh	$57.50	+$67.6M	50,845,062

Recent filings

3

Accepted (ET)
Nov 194
FIBROGEN INC0001209191-14-070177
SEC(opens sec.gov)
Jun 94
OSI PHARMACEUTICALS INC0001181431-10-032185
SEC(opens sec.gov)
Jun 84
OSI PHARMACEUTICALS INC0001181431-10-031989
SEC(opens sec.gov)

Companies

3

Address

3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU

TOKYO, M0, 103-8411